Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and targeted delivery
Interested in Adjuvatis’ drug formulation technology but want to learn more? Meet us at the Forum de la Recherche en Cancérologie organized by the Canceropole Rhone-Alpes CLARA, in April. Charlotte Primard, our CEO, will pitch Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and targeted delivery.[...]
Read More